BDH1 and lung cancer: Our finding not only suggested that BDH1 might be useful as a novel biomarker and therapeutic target for lung cancer metastases, but also imply that PARP1‐mediated AMPK‐mTOR signalling pathway might play a critical role in BDH1‐induced autophagy and lung cancer proliferation and metastases.